Association between three common genetic polymorphisms of XPC and susceptibility to heroin dependency
Akram Qasemian-Talgard1, Mostafa Saadat1
1Department of Biology, College of Sciences, Shiraz University, Shiraz, Iran.
Abstract:
As heroin and morphine produce reactive oxygen species and down-regulate several genes involved in cellular detoxification and DNA repair pathways, neurons experience DNA damage. Xeroderma pigmentosum complementation group C (XPC, OMIM: 613208) gene, which is expressed in the brain, is one of the central genes in the nucleotide excision repair pathway. Three common XPC polymorphisms (Lys939Gln, Ala499Val and PAT) are associated with reduced DNA repair capacity. In this study, the relationship between these polymorphisms and the risk of heroin dependency (HD), as well as, age of first use (AFU) for illegal drugs was investigated on 795 healthy individuals and 442 heroin dependent patients. Statistical analyses indicated that there was no significant association between the XPC polymorphisms and the risk of HD. The haplotypic frequencies of the polymorphisms showed significant difference between HD patients and healthy controls (χ2 = 16.38, df = 6, P = 0.012). Analysis indicated that the "Ala + Gln" haplotype increased the HD risk more than the "Ala + Lys" haplotype (OR = 4.21, 95% CI = 1.29-13.7, P = 0.017). In Cox proportional model, there was significant association between AFU and the Ala499Val polymorphism (Hazard ratio = 1.53, 95% CI: 1.02-2.92, P = 0.036). To investigate the effect of the linkage between the polymorphic sites, we compared the AFU among two common diplotypes ("Ala - Lys/Ala - Lys" and "Val - Lys/Val - Lys"). Statistical analysis indicated that AFU was significantly lower in "Val - Lys/Val - Lys" diplotype (t = 2.63, df = 49, P = 0.011). The present findings suggest that the XPC is a candidate polymorphic locus for AFU.
Insights
Genetic variations in the Xeroderma pigmentosum complementation group C (XPC) gene did not influence heroin dependency risk. However, specific XPC haplotypes and diplotypes were linked to increased risk and earlier age of first drug use, respectively.
Area of Science:
- Genetics
- Neuroscience
- Toxicology
Background:
- Opioid use, including heroin and morphine, induces oxidative stress and DNA damage in neurons.
- The Xeroderma pigmentosum complementation group C (XPC) gene plays a crucial role in DNA repair via the nucleotide excision repair pathway.
- Common XPC polymorphisms (Lys939Gln, Ala499Val, PAT) are known to impair DNA repair capacity.
Purpose of the Study:
- To investigate the association between XPC gene polymorphisms and the risk of heroin dependency (HD).
- To examine the relationship between XPC polymorphisms and the age of first use (AFU) of illegal drugs.
Main Methods:
- Genotyping of three common XPC polymorphisms in 795 healthy individuals and 442 heroin-dependent patients.
- Statistical analysis including haplotypic and diplotypic comparisons.
- Cox proportional hazard models were used to assess the association with AFU.
Main Results:
- No significant association was found between individual XPC polymorphisms and the risk of HD.
- Significant differences in XPC haplotypic frequencies were observed between HD patients and controls.
- The 'Ala + Gln' haplotype was associated with increased HD risk, while the 'Val - Lys/Val - Lys' diplotype correlated with a lower AFU.
Conclusions:
- XPC gene polymorphisms do not appear to be a major risk factor for developing heroin dependency.
- Specific XPC haplotypes may influence heroin dependency risk.
- XPC gene variations, particularly the Ala499Val polymorphism and related diplotypes, are associated with the age of first drug use, suggesting a role in initiation of substance use.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Drug Abuse and Addiction: Pharmacological Phenomena
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Single Nucleotide Polymorphisms-SNPs
Drug Dependence
Pleiotropy


